AIM ImmunoTech (AIM US)

Analysis

Health Care • United States

AIM ImmunoTech Inc. is an immuno-pharma company. The Company focuses onthe research and development of therapeutics to treat multiple types of cancers, as well as immune-deficiency disorders. AIM ImmunoTech operates in the United States.

Refresh

Company Presentation • 04 Feb 2026 20:00

Corporate presentation

Company Presentation • 08 Apr 2025 14:00

Investor Presentation

Company Presentation • 12 Dec 2023 20:00

Investor Presentation

Company Presentation • 17 Mar 2023 04:00

Investor Presentation

Company Presentation • 15 Aug 2023 20:30

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corporate presentation

Investor Presentation

Investor Presentation

Investor Presentation

Q2 2023